Miosis during vitreoretinal surgery

William E. Smiddy; Bert M. Glaser; Ronald G. Michels; Susan Vitale

doi:10.1097/00006982-199010010-00007

Miosis during vitreoretinal surgery

William E. Smiddy, Bert M. Glaser, Ronald G. Michels, Susan Vitale

School of Medicine

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Abstract

Maintenance of wide pupillary dilation during vitreoretinal surgery canbe important in successful completion of the operation. This study identified factors associated with intraoperative miosis. Also, flurbiprofen, a topically applied nonsteroidal antiinflammatory agent, was evaluated for its efficacy in preventing intraoperative miosis in a prospective, randomized study of 99 consecutive patients. Factors associated with intraoperative miosis included duration of surgery greater than 90 minutes, preoperative afferent pupillary defect, and recent previous surgery. Preoperative treatment with flurbiprofen did not decrease the risk of intraoperative miosis.

Original language	English (US)
Pages (from-to)	42-46
Number of pages	5
Journal	Retina
Volume	10
Issue number	1
DOIs	https://doi.org/10.1097/00006982-199010010-00007
State	Published - 1990

Keywords

Flurbiprofen
Miosis
Mydriasis
Non-steroidal anti-inflammatory drugs
Prostaglandins
Pupillary dilation
Vitreoretinal surgery

ASJC Scopus subject areas

Ophthalmology

Access to Document

10.1097/00006982-199010010-00007

Cite this

@article{359f8bce3e694f12b82598dd9c27bbe1,

title = "Miosis during vitreoretinal surgery",

abstract = "Maintenance of wide pupillary dilation during vitreoretinal surgery canbe important in successful completion of the operation. This study identified factors associated with intraoperative miosis. Also, flurbiprofen, a topically applied nonsteroidal antiinflammatory agent, was evaluated for its efficacy in preventing intraoperative miosis in a prospective, randomized study of 99 consecutive patients. Factors associated with intraoperative miosis included duration of surgery greater than 90 minutes, preoperative afferent pupillary defect, and recent previous surgery. Preoperative treatment with flurbiprofen did not decrease the risk of intraoperative miosis.",

keywords = "Flurbiprofen, Miosis, Mydriasis, Non-steroidal anti-inflammatory drugs, Prostaglandins, Pupillary dilation, Vitreoretinal surgery",

author = "Smiddy, {William E.} and Glaser, {Bert M.} and Michels, {Ronald G.} and Susan Vitale",

year = "1990",

doi = "10.1097/00006982-199010010-00007",

language = "English (US)",

volume = "10",

pages = "42--46",

journal = "Retina",

issn = "0275-004X",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - Miosis during vitreoretinal surgery

AU - Smiddy, William E.

AU - Glaser, Bert M.

AU - Michels, Ronald G.

AU - Vitale, Susan

PY - 1990

Y1 - 1990

N2 - Maintenance of wide pupillary dilation during vitreoretinal surgery canbe important in successful completion of the operation. This study identified factors associated with intraoperative miosis. Also, flurbiprofen, a topically applied nonsteroidal antiinflammatory agent, was evaluated for its efficacy in preventing intraoperative miosis in a prospective, randomized study of 99 consecutive patients. Factors associated with intraoperative miosis included duration of surgery greater than 90 minutes, preoperative afferent pupillary defect, and recent previous surgery. Preoperative treatment with flurbiprofen did not decrease the risk of intraoperative miosis.

AB - Maintenance of wide pupillary dilation during vitreoretinal surgery canbe important in successful completion of the operation. This study identified factors associated with intraoperative miosis. Also, flurbiprofen, a topically applied nonsteroidal antiinflammatory agent, was evaluated for its efficacy in preventing intraoperative miosis in a prospective, randomized study of 99 consecutive patients. Factors associated with intraoperative miosis included duration of surgery greater than 90 minutes, preoperative afferent pupillary defect, and recent previous surgery. Preoperative treatment with flurbiprofen did not decrease the risk of intraoperative miosis.

KW - Flurbiprofen

KW - Miosis

KW - Mydriasis

KW - Non-steroidal anti-inflammatory drugs

KW - Prostaglandins

KW - Pupillary dilation

KW - Vitreoretinal surgery

UR - http://www.scopus.com/inward/record.url?scp=0025297854&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025297854&partnerID=8YFLogxK

U2 - 10.1097/00006982-199010010-00007

DO - 10.1097/00006982-199010010-00007

M3 - Article

C2 - 2188314

AN - SCOPUS:0025297854

SN - 0275-004X

VL - 10

SP - 42

EP - 46

JO - Retina

JF - Retina

IS - 1

ER -

Miosis during vitreoretinal surgery

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this